Association between Pro12Ala polymorphism of the PPAR-γ2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 7, Issue 5, 2005, Pages 605-611

  Tavares, V ^a   Hirata, R D C ^a   Rodrigues, A C ^a   Monte, O ^b   Salles, J E N ^b   Scalissi, N ^b   Speranza, A C ^b   Hirata, M H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Diabetes; Insulin resistance; Metabolism; Polymorphism; PPAR ; Transcription factors

Indexed keywords

ALANINE; CHOLESTEROL; CYTOSINE; GENOMIC DNA; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; RECEPTOR SUBUNIT; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; BRAZIL; CAUCASIAN; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SIMILARITY; GENETIC TRAIT; GLUCOSE BLOOD LEVEL; HIP; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; OBESITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 23844478959     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00453.x     Document Type: Article

References (36)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 years. Diabetes Care 1992; 15: 1509-1516.
3. Horikawa Y, Iwasaki N, Hara M et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996; 384: 455-458.
4. Altshuler D, Hirschhorn JN, Klannemark M et al. The common Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
5. Clement K, Hercberg S, Passinge B et al. The Pro115Gln and Pro12Ala PPARγ gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord 2000; 24: 391-393.
6. Latruffe N, Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators for lipid metabolism. Biochimie 1997; 79: 81-94.
7. Elbrecht A, Chen Y, Cullinan CA et al. Molecular cloning, expression and characterization of human peroxisome proliferators activated receptor γ1 and γ2. Biochem Biophys Res Commun 1996; 224: 431-437.
8. Fajas L, Fruchart JC, Auwerx J. PPARγ3 mRNA: a distinct PPARγmRNA subtype transcribed from an independent promoter. FEBS Lett 1998; 438: 55-60.
9. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339: 953-959.
10. Barroso I, Gurnell M, Crowley VEF et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402: 880-883.
11. Valve R, Sivenius K, Miettinen R et al. Two polymorphisms in the peroxisome proliferators-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999; 84: 3708-3712.
12. Institute Brasileiro de Geografia e Estatística (IBGE). Brasil: 500 anos de Povoamento. IBGE 2000; Rio de Janeiro.
13. IBGE - Instituto Brasileiro de Geografia e Estatística. Censo demográfico. [Retrieved from http://www.ibge.gov.br].
14. Callegari-Jacques SM, Salzano EM. Brazilian Indian/non-Indian interactions and their effects. Ciência e Cultura 1999; 51: 166.
15. American Diabetes Association. Diagnosis classification of diabetes mellitus. Diabetes Care 2004; 27: S5-S10.
16. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
17. Östgren CJ, Lindblad U, Bog-Hansen E, Ranstam J, Melander A, Rastam L. Risk factor clustering in patients with hypertension and NIDDM. J Intern Med 1998; 243: 223-232.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RDC. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 1998; 44: 1748-1750.
21. Salazar LA, Hirata MH, Hirata RDC. Increasing the sensitivity of single-strand conformation polymorphism analysis of the LDLR gene mutations in Brazilian patients with familial hypercholesterolemia. Clin Chem Lab Med 2002; 40: 441-445.
22. Weir BS. Genetic Data Analysis II. Boston, MA: Sinauer Associates, 1996.
23. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser 2000; 894: 6-15.
24. Boson WL, Romano-Silva MA, Correa H, Falcão RP, Teixeira-Vidigal PV, De Marco L. Thiopurine methyltransferase polymorphisms in a Brazilian population. Pharmacogenomics J 2003; 3: 178-182.
25. Carvalho-Silva DR, Santos FR, Rocha J, Pena SD. The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 2001; 68: 281-286.
26. Caramori ML, Canani LH, Costa LA, Gross JL. The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with Type 2 diabetes. Diabetes 2003; 52: 3010-3013.
27. Vieira-Filho JPB, Reis AF, Kasamatsu TS et al. Influence of the polymorphisms Tpr64Arg in the β3-adrenergic receptor gene and Pro12Ala in the PPAR-γ2 gene on metabolic syndrome-related phenotypes in an indigenous population of the Brazilian Amazon. Diabetes Care 2004; 27: 621-622.
28. Yen CJ, Beamer BA, Negri C et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-274.
29. 12→Ala substitution in PPARγ is associated with resistance to development of diabetes in the general population. Diabetes 2001; 50: 891-894.
30. 12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
31. Koch M, Rett K, Maeker E et al. The PPAR-γ2 amino acid polymorphism Pro12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia 1999; 42: 758-762.
32. Mori Y, Kim-Motoyama H, Katakura T et al. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 1998; 251: 195-198.
33. Hasstedt SJ, Ren QF, Teng K, Elbein SC. Effect of the peroxisome proliferators-activated receptor [gamma]2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J Clin Endocrinol Metab 2001; 86: 536-541.
34. Ek J, Andersen G, Urhammer SA et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferators-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia 2001; 44: 1170-1176.
35. Luan J, Browne PO, Harding AH et al. Evidence for gene-nutrient interaction at the PPARγ locus. Diabetes 2001; 50: 686-689.
36. Hirschhorn JN, Altshuler D. Once and again: issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 2002; 87: 4438-4441.